ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Anastrozole and other aromatase inhibitors may increase heart disease in women
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 6150" data-attributes="member: 3"><p>As compared to tamoxifen aromatase inhibitors (AIs) may increase the risk of heart disease. Here we explored the association between the use of AIs and coronary artery disease (CAD) in a population-based observational study. In a small and heterogeneous population of 74 women with early breast cancer who received adjuvant hormonal therapy and subsequently underwent cardiac angiography, AIs significantly increased the hazard for CAD (HR 3.23, 95% confidence intervals [CI] 1.26–8.25, <em>p = .01) compared to tamoxifen. Our results suggest that therapy with AIs may increase the risk for CAD.</em></p><p><em></em></p><p><em></em></p><p><em>Read More: <a href="http://informahealthcare.com/doi/abs/10.3109/07357907.2014.880452" target="_blank">http://informahealthcare.com/doi/abs/10.3109/07357907.2014.880452</a></em></p><p><em></em></p><p><em>No heart data on men!</em></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 6150, member: 3"] As compared to tamoxifen aromatase inhibitors (AIs) may increase the risk of heart disease. Here we explored the association between the use of AIs and coronary artery disease (CAD) in a population-based observational study. In a small and heterogeneous population of 74 women with early breast cancer who received adjuvant hormonal therapy and subsequently underwent cardiac angiography, AIs significantly increased the hazard for CAD (HR 3.23, 95% confidence intervals [CI] 1.26–8.25, [I]p = .01) compared to tamoxifen. Our results suggest that therapy with AIs may increase the risk for CAD. Read More: [URL]http://informahealthcare.com/doi/abs/10.3109/07357907.2014.880452[/URL] No heart data on men![/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Anastrozole and other aromatase inhibitors may increase heart disease in women
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top